Fresenius recalls schizophrenia drug; Indian drugmaker recalls simvastatin;

> Fresenius Kabi is recalling two lots of haloperidol decanoate injections used to treat patients with schizophrenia. Notice

> CMO AMRI ($AMRI) says a sterile injectables facility in New Mexico that was taken offline after a "weather-related" event is now fully operational. Release

> India's Micro Labs is recalling 1,000 bottles of simvastatin for containing too many impurities. Notice

> India's government said within the next two weeks it will offer up a new policy intended to help bulk drug manufacturers expand their businesses over the next 5 years. Report

> A new report says that there are 300 companies in Pakistan producing substandard drugs that they sell in Afghanistan. Story

And Finally... As part of a $6.5 million deal, Amarantus Bioscience Holdings will take over from Regenicin as the plaintiff in a lawsuit against contract manufacturer Lonza for allegedly breaching an "exclusive agreement" with Regenicin. Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.